Effect of STI-571 (imatinib mesylate) in combination with retinoic acid and γ-irradiation on viability of neuroblastoma cells

Biochemical and Biophysical Research Communications

Volumn 342, Issue 4, 2006, Pages 1405-1412

  Rössler, Jochen ^a   Zambrzycka, Izabella ^a   Lagodny, Jeanette ^a   Kontny, Udo ^a   Niemeyer, Charlotte Marie ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

c Kit; Imatinib meyslate; Irradiation; Neuroblastoma; PDGF ; PDGF ; PDGFR ; PDGFR ; STI 571

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALITRETINOIN; IMATINIB; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; RETINOIC ACID; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; TYROSINE KINASE RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; FLUORESCENCE ACTIVATED CELL SORTING; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; CELL SURVIVAL; CHEMOTHERAPY, ADJUVANT; GAMMA RAYS; HUMANS; NEUROBLASTOMA; PIPERAZINES; PYRIMIDINES; TRETINOIN;

EID: 33644885475     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.02.059     Document Type: Article

References (26)

1. W.M. Crist, and L.E. Kun Common solid tumors of childhood N. Engl. J. Med. 324 1991 461 471
2. B.J. Druker, M. Talpaz, and D.J. Resta Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia N. Engl. J. Med. 344 2001 344 377
3. E. Buchdunger, C.L. Cioffi, and N. Law Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors J. Pharmacol. Exp. Ther. 295 2000 139 145
4. G.D. Demetri, M. von Mehren, and C.D. Blanke Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors N. Engl. J. Med. 347 2002 472 480
5. J. Cools, D. DeAngelo, and J. Gotlib A tyrosine kinase craeted by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopatic hypereosinophilic syndrome N. Engl. J. Med. 348 2004 1201 1214
6. J.E. McLaughlin, and H. Urich Maturing neuroblastoma and ganglioneuroblastoma: a study of four cases with long survival J. Pathol. 121 1977 19 26
7. M.S. Merchant, C.W. Woo, C.L. Mackall, and C.J. Thiele Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity J. Natl. Cancer Inst. 94 2002 1673 1679
8. G.W. Krystal, S. Honsawek, J. Litz, and E. Buchdunger The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth Clin. Cancer Res. 6 2000 3319 3326
9. D. Beck, N. Gross, C.B. Brognara, and G. Perruisseau Expression of stem cell factor and its receptor by human neuroblastoma cells and tumors Blood 86 1995 3132 3138
10. P.S. Cohen, J.P. Chan, M. Lipkunskaya, J.L. Biedler, and R.C. Seeger Expression of stem cell factor and c-kit in human neuroblastoma. The Children's Cancer Group Blood 84 1994 3465 3472
11. T. Matsui, K. Sano, and T. Tsukamoto Human neuroblastoma cells express alpha and beta platelet-derived growth factor receptors coupling with neurotrophic and chemotactic signaling J. Clin. Invest. 92 1993 1153 1160
12. R. Vitali, V. Cesi, and M.R. Nicotra c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571 Int. J. Cancer 106 2003 147 152
13. M. Krams, R. Parwaresch, and B. Sipos Expression of the c-kit receptor characterizes a subset of neuroblastomas with favorable prognosis Oncogene 23 2004 588 595
14. K. Ernestus, B. Hero, I. Leutscher, and F. Berthold Expression of the therapy relevant markers: EGF receptor, PDGF receptor and c-Kit in neuroblastoma with multitissue array Associatione Italiana per la Lotta al Neuroblastoma 2004
15. K. Beppu, J. Jaboine, M.S. Merchant, C.L. Mackall, and C.J. Thiele Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression J. Natl. Cancer Inst. 96 2004 46 55
16. G. Te Kronnie, F. Timeus, and A. Rinaldi Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition Int. J. Mol. Med. 14 2004 73 382
17. K.K. Matthay, J.G. Villablanca, and R.C. Seeger Treatment of high risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis retinoic acid N. Engl. J. Med. 341 2004 1165 1173
18. F. Timeus, N. Crescenzio, and P. Valle Stem cell factor suppresses apoptosis in neuroblastoma cell lines Exp. Hematol. 25 1997 1253 1260
19. B.J. Druker, M. Talpaz, and D.J. Resta Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia N. Engl. J. Med. 344 2001 1031 1037
20. B. Peng, and M. Hayes Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients J. Clin. Oncol. 22 2004 935 942
21. K. Scotlandi, M.C. Manara, and R. Strammiello C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions J. Clin. Oncol. 21 2003 1952 1960
22. M. Wiedmann, F. Kreth, and J. Feisthammel Imatinib mesylate (STI571; Glivec)-a new approach in the treatment of biliary tract cancer? Anticancer Drugs 14 2003 751 760
23. G. Melino, C.J. Thiele, R.A. Knight, and M. Piacentini Retinoids and the control of growth/death decisions in human neuroblastoma cell lines J. Neurooncol. 31 1997 65 83
24. A. Lasorella, A. Iavarone, and M.A. Israel Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance Cancer Res. 55 1995 4711 4716
25. K. Tieu, D.M. Zuo, and P.H. Yu Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins J. Neurosci. Res. 58 1999 426 435
26. P. Strippoli, G.P. Bagnara, and L. Montanaro Retinoic acid modulates stem cell factor secretion by human neuroblastoma cell lines Anticancer Res. 20 2000 4361 4366